Cargando…

Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer

There is a lack of predictive models to determine the prognosis of elderly patients diagnosed with Stage I small-cell lung cancer (SCLC). The purpose of this study was to establish a useful nomogram to predict cancer-specific survival (CSS) in the elderly patient population. Based on the Surveillanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yaji, Sun, Shusen, Wang, Yuwei, Xiong, Feng, Xiao, Yin, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381200/
https://www.ncbi.nlm.nih.gov/pubmed/33577444
http://dx.doi.org/10.17305/bjbms.2020.5420
_version_ 1783741322592518144
author Yang, Yaji
Sun, Shusen
Wang, Yuwei
Xiong, Feng
Xiao, Yin
Huang, Jing
author_facet Yang, Yaji
Sun, Shusen
Wang, Yuwei
Xiong, Feng
Xiao, Yin
Huang, Jing
author_sort Yang, Yaji
collection PubMed
description There is a lack of predictive models to determine the prognosis of elderly patients diagnosed with Stage I small-cell lung cancer (SCLC). The purpose of this study was to establish a useful nomogram to predict cancer-specific survival (CSS) in the elderly patient population. Based on the Surveillance, Epidemiology, and End Results registry database, patients aged ≥ 65 years with pathological AJCC (American Joint Committee on Cancer) Stage I SCLC from 2004 to 2014 were identified. The CSS was evaluated by the Kaplan-Meier method. Patients were randomly split into training and validation sets. In the training cohort, univariate analysis and multivariate analysis using the Cox regression identified risk factors that affected CSS, and the results were utilized to construct a nomogram for prediction of the 1-, 3-, and 5-year CSS rates of elderly patients with Stage I SCLC. The effectiveness of the nomogram was validated internally and externally by the bootstrap method. The clinical practicability and accuracy of the nomogram were evaluated by the concordance index (C-index), calibration curve, receiver operating characteristic curve, and decision curve analysis. In total, we extracted 1,623 elderly patients with Stage I SCLC. The median CSS was 34 months, and the 5-year CSS was 41%. Multivariate analysis revealed that histologic type, tumor size, age, and AJCC Stage were significant predictors of CSS. A nomogram was constructed according to the results of multivariate COX analysis. The C-indices of the nomogram for training and validation sets were 0.68 and 0.62, indicating that the nomogram demonstrated a favorable level of discrimination. The calibration curves exhibited satisfactory agreement between the actual observation and nomogram prediction. The net benefit of the nomogram was better than the AJCC TNM staging. A practical nomogram to predict the CSS of elderly patients with Stage I SCLC is constructed. The predictive tool is helpful for patient counseling and treatment decision-making.
format Online
Article
Text
id pubmed-8381200
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina
record_format MEDLINE/PubMed
spelling pubmed-83812002021-10-01 Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer Yang, Yaji Sun, Shusen Wang, Yuwei Xiong, Feng Xiao, Yin Huang, Jing Bosn J Basic Med Sci Research Article There is a lack of predictive models to determine the prognosis of elderly patients diagnosed with Stage I small-cell lung cancer (SCLC). The purpose of this study was to establish a useful nomogram to predict cancer-specific survival (CSS) in the elderly patient population. Based on the Surveillance, Epidemiology, and End Results registry database, patients aged ≥ 65 years with pathological AJCC (American Joint Committee on Cancer) Stage I SCLC from 2004 to 2014 were identified. The CSS was evaluated by the Kaplan-Meier method. Patients were randomly split into training and validation sets. In the training cohort, univariate analysis and multivariate analysis using the Cox regression identified risk factors that affected CSS, and the results were utilized to construct a nomogram for prediction of the 1-, 3-, and 5-year CSS rates of elderly patients with Stage I SCLC. The effectiveness of the nomogram was validated internally and externally by the bootstrap method. The clinical practicability and accuracy of the nomogram were evaluated by the concordance index (C-index), calibration curve, receiver operating characteristic curve, and decision curve analysis. In total, we extracted 1,623 elderly patients with Stage I SCLC. The median CSS was 34 months, and the 5-year CSS was 41%. Multivariate analysis revealed that histologic type, tumor size, age, and AJCC Stage were significant predictors of CSS. A nomogram was constructed according to the results of multivariate COX analysis. The C-indices of the nomogram for training and validation sets were 0.68 and 0.62, indicating that the nomogram demonstrated a favorable level of discrimination. The calibration curves exhibited satisfactory agreement between the actual observation and nomogram prediction. The net benefit of the nomogram was better than the AJCC TNM staging. A practical nomogram to predict the CSS of elderly patients with Stage I SCLC is constructed. The predictive tool is helpful for patient counseling and treatment decision-making. Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2021-10 /pmc/articles/PMC8381200/ /pubmed/33577444 http://dx.doi.org/10.17305/bjbms.2020.5420 Text en Copyright: © The Author(s) (2021) https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Research Article
Yang, Yaji
Sun, Shusen
Wang, Yuwei
Xiong, Feng
Xiao, Yin
Huang, Jing
Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
title Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
title_full Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
title_fullStr Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
title_full_unstemmed Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
title_short Development and validation of nomogram for predicting survival of elderly patients with stage I small-cell lung cancer
title_sort development and validation of nomogram for predicting survival of elderly patients with stage i small-cell lung cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381200/
https://www.ncbi.nlm.nih.gov/pubmed/33577444
http://dx.doi.org/10.17305/bjbms.2020.5420
work_keys_str_mv AT yangyaji developmentandvalidationofnomogramforpredictingsurvivalofelderlypatientswithstageismallcelllungcancer
AT sunshusen developmentandvalidationofnomogramforpredictingsurvivalofelderlypatientswithstageismallcelllungcancer
AT wangyuwei developmentandvalidationofnomogramforpredictingsurvivalofelderlypatientswithstageismallcelllungcancer
AT xiongfeng developmentandvalidationofnomogramforpredictingsurvivalofelderlypatientswithstageismallcelllungcancer
AT xiaoyin developmentandvalidationofnomogramforpredictingsurvivalofelderlypatientswithstageismallcelllungcancer
AT huangjing developmentandvalidationofnomogramforpredictingsurvivalofelderlypatientswithstageismallcelllungcancer